Comprehensive supply chain solutions for the Life Sciences
CryoPortal Login
  • English
    • Español (Spanish)
    • Français (French)
    • 日本語 (Japanese)
    • 简体中文 (Chinese)
Cryoport Systems logo
  • Industry Expertise
    • Cell Therapy
    • Gene Therapy
    • Biologics
    • Reproductive Medicine
      • Intended Parents
      • Clinics
    • Animal Health
      • Pharma & Biotech
      • Livestock
      • Companion Animal
  • Trusted Solutions
    • Shipping Systems
      • Cryogenic (below -150°C) Shipping Systems
        • Cryoport Express® Cryogenic Standard Shipping System
        • Cryoport Express® Cryogenic Combo Shipping System
        • Cryoport Express® Cryogenic HV3 Shipping System
        • Cryomax® Cryogenic Shipping System
      • Ultra Cold (-60 to -80°C) Shipping Systems
        • Cryoport Elite® Ultra Cold
      • Refrigerated (2 to 8°C) and CRT (15 to 25°C) Shipping Systems
        • Cryoport Express® C3™ Shipping System
      • Cryoport Accessories
        • Cryoport Safepak® System
    • Transportation
      • Clinical Drug Distribution
      • Commercial Drug Distribution
      • Cryoshuttle®
      • Reproductive Medicine Distribution
      • Animal Health Distribution
    • BioServices
      • Controlled Temperature Storage
      • Drug Packaging and Labelling
      • Kit Production
      • Biobanking
      • Clinical Sample Management
      • Drug Return & Destruction
      • Regulatory & QP Services
    • Consulting Services
      • Shipping Risk Assessment and Shipping Lane Qualification
      • Shipping System and Packaging Performance Qualification
      • Project/Program Management
      • Custom Packaging and Accessory Development
    • IntegriCell™ Cryopreservation
    • Data Services
  • Next-Gen Innovation
    • Cryoportal® 2
    • Cryoport Elite®
    • IntegriCell™ Cryopreservation
    • Integrated Supply Chain Centers
  • About Us
    • Our People
    • Management
    • Quality
    • Careers
    • Cryoport’s Family of Companies
  • Resources
    • Events
    • Supply Chain Blog
    • Company News & Articles
    • Brochures and Spec Sheets
    • Instructions
    • White Papers and Case Studies
    • Videos/Webinars
    • Reference Materials
      • Cryoportal® 2 Training Materials
      • Validation Package Request
      • Data Station Direction & Validation
      • Quality Change Notification Request
      • Smartpak II™ Airline Authorizations
  • Contact Us
    • Request a Quote
    • Locations
  • CYRX
CryoPortal Login
Request Info
Request a Quote
Request a Quote
Request Info Request a Quote

Supply Chain Archives

07/25/2025

Scaling with Confidence for CDMO Supply Chain Alignment

Contract Development and Manufacturing Organizations (CDMOs) play a critical role in the life sciences industry, enabling biopharma innovators to bring new therapies from development to manufacturing to patients around the world. The demand placed on CDMOs has only increased in recent years, especially as cell, gene, and biologic therapies have moved from concept to clinic at unprecedented speeds. While the technical and scientific capabilities of CDMOs have advanced to meet these challenges, one area remains a frequent source of friction and delay...the end-to-end, temperature-controlled supply chain.

Read More

Read More
06/24/2025

When Every Hour Counts: How Cryoport Systems Rapidly Mobilized to Protect INmune Bio’s Critical Clinical Materials

Biopharmaceutical development, particularly for advanced CGTs, relies on a robust infrastructure of logistics, BioServices, and temperature-controlled supply chains to ensure timely and intact delivery of drug products under stringent regulations. INmune Bio Inc. faced a challenge when a sudden biostorage site closure jeopardized a key clinical trial. However, with a strong support network, they turned to established partners like Cryoport Systems to overcome the crisis.

Read More

Read More
06/14/2025

Recognizing Donors and Advancing the Future of Cell Therapy

World Blood Donor Day serves as a reminder of the life-saving impact of voluntary blood and cell donations. These donations, often behind the scenes and not always recognized, are essential to emergency and surgical medicine and increasingly play an important role in cell and gene therapies. At Cryoport Systems, we recognize the incredible value of donors. We also understand that moving these donations safely, reliably, and under the strictest conditions, is a critical link between compassion and cure.

Read More

Read More
03/21/2025

Strengthening ATMP Development in Europe: How BioServices Centers in France Enable Efficiency and Scalability

As Advanced Therapy Medicinal Product (ATMP) developers progress from early-stage research to late-phase clinical trials and commercialization, biostorage, sample management, and regulatory-compliant logistics become increasingly complex. Efficiently managing these critical components is essential to ensure product integrity, regulatory compliance, and seamless supply chain operations.

Read More

Read More
02/04/2025

World Cancer Day: Advancing the Fight with Cell and Gene Therapies

Each year on World Cancer Day, the global community comes together to raise awareness, encourage prevention, and support those affected by cancer. It is a day of reflection, a time to recognize the immense progress that has been made in cancer research while acknowledging the work that still lies ahead. 

Read More

Read More
08/26/2024

3 Fundamental Services for Superior Master Cell Bank Management

The consistency of controlled conditions is vital throughout every step in producing advanced therapies, and the process usually begins with the secure handling and storage of the cells used for manufacturing.

Read More

Read More
06/27/2024

Cryoport Systems Celebrates Expanded French Facility with Ribbon Cutting Ceremony

Cryoport Systems commemorated the significant expansion of its Pont-du-Château facility in France with a ribbon cutting ceremony that officially launched the updated site.

Read More

Read More
04/16/2024

Overcoming Industry Obstacles for Cell and Gene Therapy Development

In the rapidly advancing world of cell and gene therapy (CGT) development, finding the proper solution to overcome common industry obstacles is a challenge that can impact entire production timelines.

Read More

Read More
02/22/2024

Examining 2023 & 2024: What’s to Come with President & CEO, Mark Sawicki

The cell and gene therapy industry is poised for many changes in 2024. With persistent challenges facing manufacturers and developers such as the retention of experienced talent or a general lack of funding for specialized therapies, the state of what’s to come feels more unsure than it has in recent years.

Read More

Read More
07/26/2023

A Glance into Our Houston & Morris Plains Global Supply Chain Centers

As cell and gene therapies continue to transform modern medicine, Cryoport Systems evolves its products and solutions to meet the needs of the industry and the patients it serves.

Read More

Read More
Load More

Categories

  • All (60)
  • Industry Insights (18)
  • Managing the Cold Chain (27)
  • Navigating Logistics (24)
  • Patient Access and Awareness (8)

Tags

  • Asia
  • Biologics
  • BioServices
  • Biostorage
  • CDMOs
  • Cell Therapy
  • Clinical Trials
  • Cold Chain Management
  • Commercialization
  • CROs
  • Cryopreservation
  • Europe
  • Gene Therapy
  • Global Logistics Tracking
  • Global Supply Chain Management
  • International Shipping
  • North America
  • Risk Mitigation
  • Standards and Compliance
  • Supply Chain Management

Subscribe to our newsletter

Never miss another update! Join our mailing list for all the latest news, events, and announcements.

  • Clinical Trial icon Trusted with 711 clinical trials
  • Approved therapies icons Supporting 18 approved therapies
  • Quality icon Robust quality standards
  • Client service icon 24/7/365 support team
  • About Us
  • Industries
  • Solutions
  • Resources
  • Innovation
  • Contact Us
  • About Us
  • Industries
  • Solutions
  • Resources
  • Innovation
  • Contact Us
Cryoport Systems logo
  • Privacy Policy
  • Terms of Use
  • Careers
Request a Quote
  • youtube
  • twitter
  • linkedin
Cryoport Systems logo

© 2024 Cryoport Systems, LLC. All rights reserved.
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

  • youtube
  • twitter
  • linkedin